Literature DB >> 8559621

Varicella vaccine: its past, present and future.

A A Gershon1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 8559621

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  5 in total

1.  Risk factors for breakthrough varicella in healthy children.

Authors:  Y J Lim; F T Chew; A Y Tan; B W Lee
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 2.  Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.

Authors:  R Snoeck; G Andrei; E De Clercq
Journal:  Drugs       Date:  1999-02       Impact factor: 11.431

Review 3.  Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination.

Authors:  Nathan B Price; Charles Grose
Journal:  Vaccines (Basel)       Date:  2021-01-06

4.  Varicella Vaccine Meningitis as a Complication of Herpes Zoster in Twice-Immunized Immunocompetent Adolescents.

Authors:  Veena Ramachandran; Stephen C Elliott; Kathie L Rogers; Randall J Cohrs; Miles Weinberger; Wallen Jackson; John E Carpenter; Charles Grose; Daniel J Bonthius
Journal:  J Child Neurol       Date:  2020-07-17       Impact factor: 1.987

Review 5.  Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus.

Authors:  Ethan H Heusel; Charles Grose
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.